• Acrylamide-based DHODH inhibitors are potential agents for treating rheumatoid arthritis

    9 days ago - By News Medical

    Human dihydroorotate dehydrogenase is a viable target for the development of therapeutics to treat cancer andimmunological diseases, such asrheumatoid arthritis, psoriasis andmultiple sclerosis.
    Read more ...